Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1183/13993003.00990-2020 http://scihub22266oqcxt.onion/10.1183/13993003.00990-2020 32312863!7173674!32312863     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Respir+J 2020 ; 55 (5): ä Nephropedia Template TP {{tp|p=32312863|t=2020. Short-term outcomes of COVID-19 and risk factors for progression |pdf=|usr=}}{{32312863}} gab.com Text Short-term outcomes of COVID-19 and risk factors for progression JO: Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=32312863 #FOAvip With a median (IQR) follow-up time of 24.0 (17.5-30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio >/=2.973, age >/=50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0 Twit Text FOAVip Short-term outcomes of COVID-19 and risk factors for progression ????Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=32312863 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32312863 #FOAvip English Wikipedia <ref>{{Cite pmid|32312863}}</ref> Short-term outcomes of COVID-19 and risk factors for progression #MMPMID32312863 Long L; Zeng X; Zhang X; Xiao W; Guo E; Zhan W; Yang X; Li C; Wu C; Xu T; Zhan C; Chen Y; Jiang M; Zhong N; Lai K Eur Respir J 2020[May]; 55 (5): ä PMID32312863show ga With a median (IQR) follow-up time of 24.0 (17.5-30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio >/=2.973, age >/=50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0 |Betacoronavirus[MESH] |COVID-19[MESH] |China[MESH] |Comorbidity[MESH] |Coronavirus Infections[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral[MESH] |Risk Factors[MESH]Short-term outcomes of COVID-19 and risk factors for progression (epmc).pdf DeepDyve Pubget Overpricing